Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

Sanofi to exercise option on third SAFEbody discovery program and sponsor combination clinical trial with muzastotug - ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

Cancer is often linked to old age. Many people think it happens late in life. But a quiet shift is happening now, especially with cancers in your stomach and bowels. It isn’t just an old person’s ...

Dr. Benjamin Weinberg, Associate Professor at Georgetown University and Principal Investigator of CytoDyn’s colorectal cancer (“CRC”) program, will present the Company’s clinical data at the ESMO ...

No one wants to be diagnosed with or go through the physical and psychological toll of cancer. Which is why, sometimes, it's ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

Curcumin contained in turmeric, the main ingredient of curry, can suppress the early onset of colorectal cancer, according to ...

Sanofi agreed to invest up to $25 million in the clinical-stage biotechnology company. Adagene said it plans to use the proceeds to fund its research and development activities, including clinical ...

TAIPEI and SHANGHAI and SAN FRANCISCO, July 1, 2025 /PRNewswire/ -- HanchorBio Inc. (7827.TWO), a global clinical-stage ...